Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Craig A. Eberhard currently holds 3,455 shares of AMYLIN PHARMACEUTICALS INC (AMLN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Craig A. Eberhard has been a net seller of AMLN stock. They have purchased $0 and sold $892.2K worth of shares.
Craig A. Eberhard's most recent insider trade was on Mar 4, 2009, when they sold 2,550 shares at $0.00 per share.
Craig A. Eberhard serves as Executive at AMYLIN PHARMACEUTICALS INC (AMLN). They have executed 37 insider transactions totaling $892.2K over their tenure at the company.
Craig A. Eberhard holds the position of Executive at AMYLIN PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Craig A. Eberhard has shown a selling trading pattern, with $0 in total purchases and $892.2K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Craig A. Eberhard was on Apr 3, 2006, when they sold $93.8K worth of AMLN shares. This transaction involved 2,000 shares at $46.89 per share.
Craig A. Eberhard currently owns 3,455 shares of AMYLIN PHARMACEUTICALS INC (AMLN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Craig A. Eberhard's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Craig A. Eberhard has 37 Form 4 filings on record as an insider at AMYLIN PHARMACEUTICALS INC.
Set alerts for Craig A. Eberhard and 40,000+ other insiders.